Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Fujifilm Launches Fujifilm Diosynth Biotechnologies | Contract Pharma

What are you searching for?

Sign in
Breaking News

Fujifilm Launches Fujifilm Diosynth Biotechnologies

The former Merck BioManufacturing Network has been named Fujifilm Diosynth Biotechnologies following the completion of FUJIFILM Corp.’s recent acquisition of the company.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The former Merck BioManufacturing Network has been named Fujifilm Diosynth Biotechnologies following the completion of FUJIFILM Corp.’s recent acquisition of the company. The acquisition includes the facilities located in Billingham, UK (MSD Biologics Ltd., formerly Avecia Biologics) and Research Triangle Park, NC (Diosynth RTP LLC).

Yuzo Toda, general manager of Pharmaceutical Products Division, FUJIFILM Corp., said, “We are delighted to complete the addition of this business to Fujifilm’s growing portfolio of healthcare and life science businesses. We intend that Fujifilm Diosynth Biotechnologies will lead the global Biologics CMO industry through continuous innovation of technologies, service delivery and quality, contributing to the enhancement of the quality of life of people worldwide. Key to this is the very talented and experienced workforce at both Billingham and RTP, backed by world-leading technologies and first-class manufacturing assets.”

Steve Bagshaw, managing director, Fujifilm Diosynth Biotechnologies, Billingham UK, added, “This transition of ownership to Fujifilm, and closer collaboration with our U.S. colleagues in NC will truly position us as a world leading contract biologics development and manufacturing business. We look forward to working with both existing and new customers to help bring their drug developments to market.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics